Skip to main content

Table 1 Demographic, clinical, and laboratory data of CKD patients

From: Correlation between neutrophil to lymphocyte ratio and platelet to lymphocyte ratio with proteinuria in different stages of chronic kidney disease

Demographics

 Age (years), mean ± SD

58.1 ± 13.5

 Sex (male, %)

50 (58.8%)

Comorbidities

 Hypertension

21 (24.7%)

 Glomerulonephritis

16 (18.8%)

 Diabetes

9 (10.6%)

 IgA nephropathy

2 (2.4%)

 Multiple conditions (diabetes/hypertension/ischemic heart disease)

24 (28.2%)

Medications

 ACE inhibitors

15 (17.65%)

 ARB medications

43 (50.59%)

Laboratory data

 Serum creatinine (μmol/L)

175.3 ± 70.9

 e-GFR (ml/min/1.73m2)

36.00 (24.50–51.50)

 ESR (mm/h)

25.00 (15.00–46.50)

 UPCR (mg/mmol)

170.00 (59.65–297.12)

 WBC count (× 109/L)

8.12 ± 1.7

 Neutrophil count (× 109/L)

5.40 ± 1.51

 Lymphocyte count (× 109/L)

2.0 (1.70–2.30)

 Platelet count (× 109/L)

267.00 (243.50–290.00)

 NLR

2.59 ± 0.79

 PLR

124 (110.20–139.27)

  1. Data are presented as total numbers, percentages, means ± standard deviations, or median with interquartile range (IQR). CKD chronic kidney disease, ACE angiotensin-converting enzyme, ARB angiotensin receptor blockers, e-GFR estimated glomerular filtration rate, ESR erythrocyte sedimentation rate, UPCR urine protein creatinine ratio, WBC white blood cell, NLR neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio